These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 9056592)

  • 41. Evaluation of partial area under the curve in bioequivalence studies using destructive sampling design.
    Martinez MN; Gao S
    J Vet Pharmacol Ther; 2021 Jul; 44(4):628-643. PubMed ID: 33615485
    [TBL] [Abstract][Full Text] [Related]  

  • 42. On easily interpretable multivariate reference regions of rectangular shape.
    Wellek S
    Biom J; 2011 May; 53(3):491-511. PubMed ID: 22223253
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bioequivalence.
    Rescigno A
    Pharm Res; 1992 Jul; 9(7):925-8. PubMed ID: 1438007
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Detection of data manipulation in bioequivalence trials.
    Fuglsang A
    Eur J Pharm Sci; 2021 Jan; 156():105595. PubMed ID: 33053409
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A simple BASIC program for the calculation of nonparametric confidence intervals in bioequivalence testing.
    Meineke I
    Comput Methods Programs Biomed; 1987 Feb; 24(1):65-71. PubMed ID: 3829651
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of product bioequivalence when subject blood volume necessitates limited sampling strategies.
    Martinez MN; Gao S
    J Vet Pharmacol Ther; 2023 Sep; 46(5):276-299. PubMed ID: 37010032
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An improved intercept method for the assessment of absorption rate in bioequivalence studies.
    Macheras P; Symillides M; Reppas C
    Pharm Res; 1996 Nov; 13(11):1755-8. PubMed ID: 8956348
    [No Abstract]   [Full Text] [Related]  

  • 48. A parametric approach to population bioequivalence.
    Hauck WW; Bois FY; Hyslop T; Gee L; Anderson S
    Stat Med; 1997 Feb; 16(4):441-54. PubMed ID: 9044531
    [No Abstract]   [Full Text] [Related]  

  • 49. Commentary on individual bioequivalence by M.-L. Chen.
    Hauck WW; Anderson S
    J Biopharm Stat; 1997 Mar; 7(1):13-6. PubMed ID: 9056582
    [No Abstract]   [Full Text] [Related]  

  • 50. Evaluation of Excipient Risk in BCS Class I and III Biowaivers.
    Metry M; Polli JE
    AAPS J; 2022 Jan; 24(1):20. PubMed ID: 34988701
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Multivariate Assessment for Bioequivalence Based on the Correlation of Random Effect.
    An H; Shin D
    Drug Des Devel Ther; 2021; 15():3675-3683. PubMed ID: 34465979
    [TBL] [Abstract][Full Text] [Related]  

  • 52. When is a metric not a metric? Remarks on direct curve comparison in bioequivalence studies.
    Jawień W
    J Pharmacokinet Pharmacodyn; 2009 Jun; 36(3):261-79. PubMed ID: 19544090
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bioequivalence testing by statistical shape analysis.
    Pereira LM
    J Pharmacokinet Pharmacodyn; 2007 Aug; 34(4):451-84. PubMed ID: 17554610
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Novel direct curve comparison metrics for bioequivalence.
    Polli JE; McLean AM
    Pharm Res; 2001 Jun; 18(6):734-41. PubMed ID: 11474775
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of direct curve comparison metrics applied to pharmacokinetic profiles and relative bioavailability and bioequivalence.
    Marston SA; Polli JE
    Pharm Res; 1997 Oct; 14(10):1363-9. PubMed ID: 9358548
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The multivariate assessment of bioequivalence.
    Chinchilli VM; Elswick RK
    J Biopharm Stat; 1997 Mar; 7(1):113-23. PubMed ID: 9056592
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A two one-sided tests procedure for assessment of individual bioequivalence.
    Liu J; Chow SC
    J Biopharm Stat; 1997 Mar; 7(1):49-61. PubMed ID: 9056588
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Analysis of multiple-dose bioequivalence studies.
    Chinchilli VM; Esinhart JD; Barr WH
    J Biopharm Stat; 1994 Nov; 4(3):423-35. PubMed ID: 7881454
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Model-based analyses of bioequivalence crossover trials using the stochastic approximation expectation maximisation algorithm.
    Dubois A; Lavielle M; Gsteiger S; Pigeolet E; Mentré F
    Stat Med; 2011 Sep; 30(21):2582-600. PubMed ID: 21793036
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Discussion of individual bioequivalence by M.-L. Chen.
    Gould AL
    J Biopharm Stat; 1997 Mar; 7(1):23-9. PubMed ID: 9056584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.